Nishihara E, Fukata S, Hirokawa M, Higuchi M, Ito M, Nishikawa M, Miyauchi A, Matsuse M, Mitsutake N, Ito Y, Hishinuma A, Kogai T, Akamizu T.

Nodule-specific NRF2-targeted upregulation in patients with KEAP1 mutations and familial nontoxic multinodular goiter.

J Clin Endocrinol Metab. 2025 Mar 17;110(4):973-982.

​

Ito Y, Miyauchi A, Hirokawa M, Kawakami M, Kihara M, Onoda N, Miya A.

A high Ki-67 labeling index and high thyroglobulin doubling rate are significant predictors of excision-site recurrence of papillary thyroid carcinoma following airway resection for locally curative surgery.

World J Surg. 2024 Oct;48(10):2452-2462.

​

Jung CK, Liu Z, Hirokawa M, Bychkov A.

Histological clues of DICER1 mutations in thyroid nodules.

Virchows Arch. 2024 Oct;485(4):755-757.

​​

Agarwal S, Jung CK, Gaddam P, Hirokawa M, Higashiyama T, Hang JF, Lai WA, Keelawat S, Liu Z, Na HY, Park SY, Fukuoka J, Satoh S, Mussazhanova Z, Nakashima M, Kakudo K, Bychkov A.

PD-L1 Expression and Its Modulating Factors in Anaplastic Thyroid Carcinoma: A Multi-institutional Study.

Am J Surg Pathol. 2024 Oct 1;48(10):1233-1244.

​

Hirokawa M, Suzuki A.

Unraveling the myth: immunocytochemistry applications in thyroid lesions.

Acta Cytol. 2025;69(1):7-15.

​

Ayana Suzuki, Mitsuyoshi Hirokawa, Makoto Kawakami, Yuko Hashimoto, Moe Muramatsu, Akira Miyauchi, Takashi Akamizu

Clinicopathological characteristics of methotrexate-related lymphoproliferative disorder of the thyroid: A study of 11 patients

Ann Diagn Pathol. 2024 Dec:73:152354.

​

Kanematsu R, Hirokawa M, Suzuki A, Higuchi M, Miyauchi A, Akamizu T.

Diagnostic significance of clay-like materials aspirated from thyroid nodules

CytoJournal 2024 May 22:21:17.

​​

Haq F, Park G, Jeon S, Hirokawa M, Jung CK.

Utilizing Immunoglobulin IgG4 Immunohistochemistry for Risk Stratification in Patients with Papillary Thyroid Carcinoma Associated with Hashimoto Thyroiditis.

Endocrinol Metab (Seoul). 2024 Jun;39(3):468-478.

​

Kihara M, Miyauchi A, Hirokawa M, Suzuki A, Akamizu T.

Availability of Serum Levels of Carbohydrate Antigen 19-9 (CA19-9) as a Surrogate Tumor Marker for Papillary Thyroid Carcinoma.

JMA J. 2024 Apr 15;7(2):250-257. doi: 10.31662/jmaj.2023-0180. Epub 2024 Feb 9. PMID: 38721086; PMCID: PMC11074524.

​

Suzuki A, Hirokawa M, Otsuka I, Miyauchi A, Akamizu T.

Calcium oxalate crystals as a cause of multiple punctate echogenic foci in benign thyroid lesions.

J Med Ultrason (2001). 2024 Jul;51(3):517-523.

​​

Suzuki A, Hirokawa M, Otsuka I, Miya A, Miyauchi A, Akamizu T.

Utility of solid area diameter in management of cystic papillary thyroid carcinoma.

Endocr Connect. 2024;13(6):e240040

​​

Kim C, Agarwal S, Bychkov A, Hang JF, Harahap AS, Hirokawa M, Kakudo K, Keelawat S, Liu CY, Liu Z, Nguyen TP, Rana C, Vuong HG, Zhu Y, Jung CK.

Differentiating BRAF V600E- and RAS-like alterations in encapsulated follicular patterned tumors through histologic features: a validation study.

Virchows Arch. 2024 Apr;484(4):645-656. doi: 10.1007/s00428-024-03761-4. Epub 2024 Feb 16. PMID: 38366204.

​

Hatanaka KC, Nakamura K, Katoh R, Ito K, Hirokawa M, Miyauchi A, Matsuno Y, Kano S, Okada Y, Mori Joji, Ito Y, Hatanaka Y.

Impact of the quality of resected thyroid cancer tissue sample on next-generation sequencing testing.

Pathol Int. 2024 Feb;74(2):77-86.

​​

Suzuki A, Nojima S, Tahara S, Motooka D, Kohara M, Okuzaki D, Hirokawa M, Morii E.

Identification of invasive subpopulations using spatial transcriptome analysis in thyroid follicular tumors.

J Pathol Transl Med. 2024 Jan;58(1):22-28.